Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells.
Acute myocardial infarction with spontaneous reperfusion: clinical characteristics and optimal timing for revascularization.
Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart.
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go? Blood Purif. 2016; 41(1-3):139-43.
View in:
PubMed
subject areas
Albuminuria
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Blood Pressure
Comorbidity
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diabetic Nephropathies
Disease Management
Humans
Hypertension
Practice Guidelines as Topic
Randomized Controlled Trials as Topic